New Zealand markets closed

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
106.01+1.60 (+1.53%)
At close: 4:00PM EDT
106.01 0.00 (0.00%)
After hours: 07:17PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
129,910,000
126,946,000
122,021,000
111,831,000
111,696,000
Cost of revenue
22,132,000
20,932,000
20,088,000
17,617,000
17,632,000
Gross profit
107,778,000
106,014,000
101,933,000
94,214,000
94,064,000
Operating expenses
Research development
16,282,000
15,462,000
14,220,000
14,805,000
14,014,000
Selling general and administrative
38,237,000
36,886,000
35,830,000
33,313,000
32,124,000
Total operating expenses
54,031,000
51,888,000
49,450,000
46,966,000
45,097,000
Operating income or loss
53,747,000
54,126,000
52,483,000
47,248,000
48,967,000
Interest expense
-678,000
390,000
220,000
85,000
90,000
Total other income/expenses net
-
-793,000
-3,494,000
473,000
-198,000
Income before tax
55,548,000
53,130,000
48,553,000
47,615,000
48,680,000
Income tax expense
11,186,000
10,992,000
9,602,000
8,987,000
10,550,000
Income from continuing operations
44,362,000
42,138,000
38,951,000
38,628,000
38,130,000
Net income
44,362,000
42,138,000
38,951,000
38,628,000
38,130,000
Net income available to common shareholders
44,362,000
42,138,000
38,951,000
38,628,000
38,130,000
Basic EPS
-
18.05
16.41
15.96
15.42
Diluted EPS
-
18.01
16.38
15.93
15.39
Basic average shares
-
2,333,900
2,374,299
2,419,603
2,473,218
Diluted average shares
-
2,340,000
2,378,658
2,424,417
2,478,093
EBITDA
-
59,273,000
54,434,000
51,625,000
51,952,000